article thumbnail

Clinical trial finds finerenone reduces worsening heart failure and cardiovascular death

Science Daily: Pharmacology News

Finerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or preserved ejection fraction, according to an international clinical trial.

article thumbnail

New Gene therapy trial shows restored hearing and speech in children born deaf, treated in both ears

Science Daily: Pharmacology News

A new clinical trial of five children with inherited deafness found administering gene therapy in both ears led to restored hearing and speech, and additional gains including sound source localization, ability to hear in noisy environments, and for two children, abillity to appreciate music.

Therapies 309
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ventyx’s TYK2 drug suffers second setback

BioPharma Drive: Drug Pricing

The company claimed “higher than anticipated” scores from trial volunteers on placebo led to the disappointing data, prompting it to halt internal trials.

article thumbnail

Single-dose gene therapy is potentially life-changing for adults with hemophilia B

Science Daily: Pharmacology News

Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the new results of an international Phase III clinical trial.

Therapies 300
article thumbnail

Early-stage stem cell therapy trial shows promise for treating progressive MS

Science Daily: Pharmacology News

An international team has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.

Therapies 237
article thumbnail

Weight-Loss Drug Zepbound May Lower Heart Failure Deaths

Drugs.com

21, 2024 -- A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows.The test of tirzepatide, brand named Zepbound, included 731 patients with. THURSDAY, Nov.

article thumbnail

How the FSP Model Augments Biotech Sponsors’ Internal Capabilities

PPD

FSP solutions are widely used in biotech Biotech companies of any size can benefit from using a contract research organization (CRO) to fulfill trial-related functions and services. With FSO, all tasks for a clinical trial are outsourced. are outsourced.